Drug profile · INN
nitrofurantoin
ARX-NITROFURANTOIN
nitrofurantoin (ARX-NITROFURANTOIN) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — nitrofurantoin
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
nitrofurantoin (ARX-NITROFURANTOIN) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is nitrofurantoin?
nitrofurantoin (ARX-NITROFURANTOIN) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nitrofurantoin?
ARX-NITROFURANTOIN is a marketed brand name for nitrofurantoin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nitrofurantoin?
nitrofurantoin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.